ACUTA CAPITAL PARTNERS, LLC - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 131 filers reported holding XENON PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.4%.

Quarter-by-quarter ownership
ACUTA CAPITAL PARTNERS, LLC ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$9,837,000
+18.7%
272,5000.0%4.24%
-8.3%
Q2 2022$8,289,000
+20.5%
272,500
+21.1%
4.62%
+43.7%
Q1 2022$6,878,000
-2.1%
225,0000.0%3.21%
+8.8%
Q4 2021$7,029,000
+10.2%
225,000
-46.1%
2.96%
+31.3%
Q3 2021$6,378,000
-17.9%
417,4090.0%2.25%
-27.6%
Q2 2021$7,772,000
+5.3%
417,409
+1.2%
3.11%
+16.7%
Q1 2021$7,384,000
+500.3%
412,500
+415.6%
2.66%
+694.6%
Q4 2020$1,230,000
-63.0%
80,000
-73.3%
0.34%
-62.9%
Q3 2020$3,321,000
-48.8%
300,000
-42.0%
0.90%
-51.9%
Q2 2020$6,489,000
-9.0%
517,500
-17.7%
1.88%
-45.7%
Q1 2020$7,127,000
-40.7%
628,500
-31.5%
3.45%
+15.9%
Q4 2019$12,028,000
+90.0%
917,500
+30.6%
2.98%
-34.8%
Q3 2019$6,330,000
-8.5%
702,500
+0.1%
4.57%
+85.7%
Q2 2019$6,917,000
+23.2%
701,500
+27.0%
2.46%
-7.8%
Q1 2019$5,613,000
+65.5%
552,500
+2.8%
2.67%
+3.2%
Q4 2018$3,392,000
-46.7%
537,500
+11.4%
2.59%
+13.9%
Q3 2018$6,369,000
+53.8%
482,500
+7.2%
2.27%
+208.3%
Q2 2018$4,140,000450,0000.74%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 790,000$12,071,0003.53%
GREAT POINT PARTNERS LLC 700,000$10,696,0002.49%
COMMODORE CAPITAL LP 579,432$8,854,0002.33%
ACUTA CAPITAL PARTNERS, LLC 417,409$6,378,0002.25%
DAFNA Capital Management LLC 406,535$6,212,0001.65%
Tri Locum Partners LP 264,134$4,036,0001.60%
Parkman Healthcare Partners LLC 311,207$4,755,0001.20%
Ghost Tree Capital, LLC 250,000$3,820,0001.12%
Nan Fung Group Holdings Ltd 197,880$3,024,0000.97%
BVF INC/IL 1,571,778$24,017,0000.94%
View complete list of XENON PHARMACEUTICALS INC shareholders